Imported vaccine-associated paralytic poliomyelitis--United States, 2005.
Paralytic poliomyelitis is rare in the United States because of the success of universal childhood immunization and the Global Polio Eradication Initiative. Poliovirus vaccine was introduced in the 1950s. Since then, the United States has eliminated indigenous wild poliovirus transmission, controlled imported wild poliovirus cases, and, through a vaccine policy change (i.e., from live, attenuated oral polio vaccine [OPV] to inactivated polio vaccine [IPV]), eliminated vaccine-associated paralytic polio (VAPP) cases. The most recent VAPP case occurred in 1999. The primary risk for paralytic polio for U.S. residents is through travel to countries where polio remains endemic or where polio outbreaks are occurring. This report describes the first known occurrence of imported VAPP in an unvaccinated U.S. adult who traveled abroad, where she likely was exposed through contact with an infant recently vaccinated with OPV. This case highlights the previously unrecognized risk for paralytic polio among unvaccinated persons exposed to OPV during travel abroad.
D000328:Adult; D005260:Female; D006801:Humans; D011051:Poliomyelitis / Q000453:epidemiology / Q000635:transmission*; D011055:Poliovirus Vaccine, Oral; D012306:Risk; D014195:Travel; D014481:United States / Q000453:epidemiology
D011055:Poliovirus Vaccine, Oral